Narayana Hrudayalaya Limited Share Price & Stock Analysis

Narayana Hrudayalaya Limited (NSE: NH, BSE: 539551) is a Bengaluru, Karnataka-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹37,907 Cr, it ranks #245 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 46 in Hospitals and Healthcare Centers. At ₹1,868.00 (as of 16 Nov 2026), the share price is 10.8% below its 52-week high of ₹2,093.30 and 17.6% above its 52-week low of ₹1,589.00. The share price is up 2.8% over one year and up 1.6% over three months.

Key Metrics

Current Price₹1,868.00
Market Cap₹37,907 Cr
NSE SymbolNH
BSE Code539551
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Facilities > Hospitals and Healthcare Centers
P/E Ratio46.2
Return on Equity19.85%
Return on Assets7.40%
52-Week Range₹1,589.00 – ₹2,093.30
1-Year Price Change+2.8%
3-Month Price Change+1.6%
Beta (1Y)0.04
Dividend Yield0.24%
HeadquartersBengaluru, Karnataka
Websitewww.narayanahealth.org

Latest Quarterly Results — Q2 FY27

Revenue₹2,844 Cr
Net Profit₹301 Cr
Net Margin10.6%
EPS (Basic)₹14.82
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Narayana Hrudayalaya Limited Quarterly Revenue and Profit Trend

Narayana Hrudayalaya Limited reported revenue of ₹2,844 Cr in Q2 FY27, up 73.0% from ₹1,644 Cr in Q2 FY26 and up 6.0% from ₹2,684 Cr in Q1 FY27. It posted a net profit of ₹301 Cr for the quarter, against a net profit of ₹259 Cr in Q2 FY26 (up 16.5%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹1,475 Cr (Q4 FY25) to ₹2,844 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹2,844 Cr₹301 Cr10.6%
Q1 FY27₹2,684 Cr₹207 Cr7.7%
Q4 FY26₹2,594 Cr₹224 Cr8.6%
Q3 FY26₹2,151 Cr₹127 Cr5.9%
Q2 FY26₹1,644 Cr₹259 Cr15.7%
Q1 FY26₹1,507 Cr₹197 Cr13.1%
Q4 FY25₹1,475 Cr₹197 Cr13.4%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 63.27% of Narayana Hrudayalaya Limited's shares as of Sept 2026, against 63.85% in Sept 2025 (−0.58 percentage points). Delivery averaged 51.6% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Narayana Hrudayalaya Limited

Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services.

Products and Services

1. Medical and Healthcare Services-This segment operates a network of multispecialty and superspeciality hospitals that offer medical and healthcare services.

Business Segments

1. Medical and Healthcare Related Services-95.7% 2. Others-4.8%

Narayana Hrudayalaya Limited vs Peers — Hospitals and Healthcare Centers

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Apollo Hospitals Enterprise Limited₹1,23,712 Cr6321.50%₹7,615 Cr+11.6%
Max Healthcare Institute Ltd₹91,978 Cr63.914.33%₹2,569 Cr-16.6%
Manipal Health Enterprises Ltd₹89,110 Cr88.4—₹3,399 Cr—
Aster Dm Healthcare Limited (Asterdm)₹63,041 Cr97.610.07%₹2,829 Cr+4.3%
Fortis Healthcare Ltd.₹58,283 Cr55.111.01%₹2,735 Cr-25.1%
Global Health Ltd (Medanta)₹38,422 Cr69.715.03%₹1,469 Cr+16.2%
Narayana Hrudayalaya Limited₹37,907 Cr46.219.85%₹2,844 Cr+2.8%
Krishna Institute Of Medical Science (KIMS)₹29,056 Cr120.69.72%₹1,344 Cr+0.2%
Dr. Agarwal's Health Care Limited₹17,568 Cr131.98.31%₹655 Cr+9.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Narayana Hrudayalaya Limited?

Narayana Hrudayalaya Limited is trading at ₹1,868.00, with a market capitalisation of ₹37,907 Cr.

Which sector does Narayana Hrudayalaya Limited belong to?

Narayana Hrudayalaya Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).

What are the key financial ratios of Narayana Hrudayalaya Limited?

Narayana Hrudayalaya Limited has a P/E of 46.2 and a return on equity of 19.85%.

What is the stock symbol of Narayana Hrudayalaya Limited?

Narayana Hrudayalaya Limited is listed on the NSE under the symbol NH and on the BSE under the scrip code 539551.

How has Narayana Hrudayalaya Limited's share price moved over the past year?

Narayana Hrudayalaya Limited's share price is up 2.8% over one year and up 1.6% over three months. Its 52-week range is ₹1,589.00 to ₹2,093.30.

What were Narayana Hrudayalaya Limited's latest quarterly results?

In Q2 FY27, Narayana Hrudayalaya Limited reported revenue of ₹2,844 Cr and net profit of ₹301 Cr, with basic EPS of ₹14.82 (consolidated, parsed from the company's exchange filing).

How have Narayana Hrudayalaya Limited's revenue and profit changed over the past year?

Narayana Hrudayalaya Limited reported revenue of ₹2,844 Cr in Q2 FY27, up 73.0% from ₹1,644 Cr in Q2 FY26 and up 6.0% from ₹2,684 Cr in Q1 FY27.

What is the promoter holding in Narayana Hrudayalaya Limited?

Promoters held 63.27% of Narayana Hrudayalaya Limited's shares as of Sept 2026, against 63.85% in Sept 2025 (−0.58 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.